Daxila Ddr 60mg Capsules (30s)

Daxila DDR is a proton pump inhibitor containing dexlansoprazole 60 mg in a dual delayed-release capsule formulation. It reduces stomach acid and is used for acid reflux-related conditions such as gastroesophageal reflux disease and erosive esophagitis.

• Manufacturer Name: Scilife
• Drug Class: Proton pump inhibitor
• Dosage Form: Dual Delayed-Release Capsule
• Storage: Store at room temperature in a dry place, protected from excessive heat and moisture, and keep out of reach of children.
• Pack Size: Pack of 30 Capsules

Daxila Ddr 60mg Capsules (30s) Available Online in Pakistan

Dwatson offers Daxila Ddr 60mg Capsules (30s) at Rs.1319, with fast, discreet delivery across Pakistan.

• Dexlansoprazole 60 mg

• Healing of erosive esophagitis
• Maintenance of healed erosive esophagitis
• Treatment of symptomatic gastroesophageal reflux disease
• Relief of heartburn associated with acid reflux

For Adult

• Take strictly as prescribed by a doctor.
• For healing erosive esophagitis, the usual adult dose is 60 mg once daily for up to 8 weeks.
• For symptomatic non-erosive gastroesophageal reflux disease, the usual dose is 30 mg once daily; this 60 mg product should be used only when specifically prescribed.
• Swallow the capsule whole with water. Do not crush or chew it.
• It may generally be taken with or without food.

For Children

• Use in children and adolescents only under medical supervision.
• Dexlansoprazole has been used in patients aged 12 years and older for certain gastroesophageal reflux conditions.
• The 60 mg strength is not appropriate for routine self-use in children and should be prescribed according to age, condition, and clinical need.
• Safety and dosing in children younger than 12 years have not been established for this product.

Side Effects

• Common effects may include headache, diarrhea, abdominal pain, nausea, vomiting, flatulence, constipation, and upper respiratory symptoms.
• Seek urgent medical attention for facial or throat swelling, breathing difficulty, severe skin reactions, persistent watery diarrhea, severe rash, seizures, irregular heartbeat, or symptoms of severe allergy.
• Long-term use may be associated with low magnesium, vitamin B12 deficiency, bone fractures, kidney inflammation, and increased risk of certain intestinal infections.

Contraindications

• Do not use in patients with a known allergy to dexlansoprazole, other proton pump inhibitors, or any capsule ingredient.
• Do not use with rilpivirine-containing medicines.
• Seek medical advice before use if there is unexplained weight loss, difficulty swallowing, vomiting blood, black stools, persistent vomiting, severe abdominal pain, or suspected gastrointestinal malignancy.
• Use cautiously in patients with severe liver impairment, osteoporosis, vitamin B12 deficiency, low magnesium, or a history of Clostridioides difficile infection.
• Long-term or high-dose treatment should be medically monitored.

Precautions & Warnings

• May interact with medicines whose absorption depends on stomach acidity, including some antifungals and certain antiretroviral medicines.
• Rilpivirine-containing products are contraindicated; atazanavir- or nelfinavir-containing products are generally avoided unless specifically directed by a specialist.
• Use caution with warfarin, digoxin, tacrolimus, clopidogrel, methotrexate at high doses, and medicines metabolized through CYP2C19.
• Tell the doctor about all prescription medicines, over-the-counter products, vitamins, and herbal supplements.
• Food does not usually prevent administration, but follow the prescriber’s instructions.

• Use during pregnancy only when clearly needed and recommended by a healthcare professional.
• Available human safety information is limited; the potential benefit should be weighed against possible risk.
• It is not known whether dexlansoprazole passes into human breast milk. Consult a doctor before breastfeeding while using it.